APA (7th ed.) Citation

Hardy-Abeloos, C., Pinotti, R., & Gabrilove, J. (2020). Ibrutinib dose modifications in the management of CLL. Journal of Hematology & Oncology, 13(1), 1. https://doi.org/10.1186/s13045-020-00870-w

Chicago Style (17th ed.) Citation

Hardy-Abeloos, Camille, Rachel Pinotti, and Janice Gabrilove. "Ibrutinib Dose Modifications in the Management of CLL." Journal of Hematology & Oncology 13, no. 1 (2020): 1. https://doi.org/10.1186/s13045-020-00870-w.

MLA (9th ed.) Citation

Hardy-Abeloos, Camille, et al. "Ibrutinib Dose Modifications in the Management of CLL." Journal of Hematology & Oncology, vol. 13, no. 1, 2020, p. 1, https://doi.org/10.1186/s13045-020-00870-w.